Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a ...

A new class of drugs is set to join their ranks and has the potential to eclipse them all—GLP-1 receptor agonists. These drugs mimic the action of a naturally occurring hormone, glucagon-like ...

A Lancet study suggests that popular weight loss drugs could lead to muscle loss. Reserachers recommend combining these ...

How can one class of drug do so much ... For patients, the new uses of glp-1 drugs would mean not just longer, healthier and more productive lives, but happier ones, too. In a world of abundance ...

BioNTech is acquiring Chinese biotech Biotheus for $800 million upfront plus $150 million in milestones, gaining multiple ...

of which just more than 8,000 were taking either GLP-1 drugs such as Ozempic or the similar GIP class of drugs that Eli Lilly’s Mounjaro belongs to.

A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present just as many opportunities as pitfalls. People taking the drugs do ...

Opens in a new tab or window Labels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep sedation. This drug class, involving injectable ...

WEDNESDAY, Nov. 13, 2024 (HealthDay News) -- The blockbuster GLP-1 drug semaglutide ( Ozempic, Wegovy) could curb drinking ...

These diabetes drugs for weight loss include: GLP-1s. What are GLP-1 medications? Glucagon-like peptide-1 receptor agonists (GLP-1s for short) are a class of drugs that stimulate the GLP-1 ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...